Product Overview?
D-Cycloserine (CAS: 68-41-7) is a cyclic serine derivative and broad-spectrum antibiotic with the molecular formula ?C?H?N?O?? (MW: 102.09). It inhibits bacterial cell wall synthesis by competitively blocking D-alanine incorporation, making it critical for treating drug-resistant tuberculosis (TB) and urinary tract infections. Additionally, it acts as a partial NMDA receptor agonist, supporting neuroscience research in cognitive enhancement, PTSD, and anxiety disorders. This white crystalline powder is also used as a biochemical intermediate in enzyme studies.

? ?Key Advantages?
? ?High Purity?: ≥99% purity (HPLC/GC tested), ensuring reliability for pharmaceutical and research applications.
? ?Antibacterial Potency?: Effective against multidrug-resistant Mycobacterium tuberculosis with MIC values of 10-20 μg/mL.
? ?Water Solubility?: Soluble in water (50 mg/mL) and stable at melting point 155-156°C for flexible formulation.

?? ?Application Fields?

• ?Pharmaceuticals?: First-line adjuvant for drug-resistant TB therapy and urinary tract infection treatment.

• ?Neuroscience?: NMDA receptor modulation for studies on memory enhancement and neuropsychiatric disorders.

• ?Biochemical Synthesis?: Key intermediate in peptidoglycan inhibitor development and enzymatic activity assays.

?? ?Quality Assurance?

• Produced in ?GMP-certified facilities? compliant with ?USP/EP standards?.

• Rigorous QC via ?HPLC, NMR, and mass spectrometry? for batch consistency.

• Complies with ?MSDS guidelines? for safe handling, storage, and non-hazardous classification.

?? ?Market Insights?
The global anti-TB drug market is projected to reach ?$2.1B by 2030? (CAGR 5.7%), driven by rising multidrug-resistant TB cases. D-Cycloserine’s dual role in infectious disease and neuroscience research underscores its growing demand in pharmaceutical and academic sectors.